|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/55 | |
| A61K 47/60 | |||
| A61P 1/00 | |||
| A61P 9/04 | |||
| A61P 9/12 | |||
| A61P 13/12 | |||
| A61K 31/18 | |||
| A61K 31/4025 | |||
| A61K 31/4545 | |||
| C07D 207/09 | |||
| C07D 207/12 | |||
| C07D 211/14 | |||
| C07D 211/56 |
| (11) | Number of the document | 2887964 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13753904.5 |
| Date of filing the European patent application | 2013-08-20 | |
| (97) | Date of publication of the European application | 2015-07-01 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2013/052192 |
| Date | 2013-08-20 |
| (87) | Number | WO 2014/029983 |
| Date | 2014-02-27 |
| (30) | Number | Date | Country code |
| 201261691635 P | 2012-08-21 | US |
| (72) |
LEADBETTER, Michael, US
BELL, Noah, US
LEWIS, Jason, US
JACOBS, Jeffrey, US
CARRERAS, Christopher, US
|
| (73) |
Ardelyx, Inc.,
34175 Ardenwood Blvd., Fremont, California 94555,
US
|
| (54) | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS |
| COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS |